The anaemia of Plasmodium vivax malaria

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Douglas, Nicholas M ^a,b,c   Anstey, Nicholas M ^a,c   Buffet, Pierre A ^d,e,f   Poespoprodjo, Jeanne R ^a,g,h   Yeo, Tsin W ^a,c   White, Nicholas J ^b,i   Price, Ric N ^a,b,c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL DARWIN HOSPITAL   (Australia)

^d INSERM   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f INSTITUT PASTEUR   (France)

^g Mimika District Health Authority   (Indonesia)

^h Papuan Health and Community Development Foundation   (Indonesia)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anaemia; Epidemiology; Malaria; Pathogenesis; Plasmodium vivax

Indexed keywords

ARTEMISININ DERIVATIVE; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE;

ANEMIA; ASCARIS LUMBRICOIDES; BLOOD TRANSFUSION; DRUG WITHDRAWAL; ERYTHROCYTE; ERYTHROPOIESIS; HEMATOCRIT; HEMOLYSIS; HUMAN; MORBIDITY; MORTALITY; PATHOGENESIS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; REVIEW;

ANEMIA; ANTIMALARIALS; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX;

EID: 84862234371     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-135     Document Type: Review

References (203)

1. The international limits and population at risk of Plasmodium vivax transmission in 2009. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IRF, Baird JK, Snow RW, Hay SI, PLoS Negl Trop Dis 2010 4 774
2. Evolutionary and historical aspects of the burden of malaria. Carter R, Mendis KN, Clin Microbiol Rev 2002 15 564 594
3. Plasmodium vivax: who cares? Galinski MR, Barnwell JW, Malar J 2008 7 Suppl 1 9
4. Vivax malaria: neglected and not benign. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, Am J Trop Med Hyg 2007 77 79 87
5. Artemisinin combination therapy for vivax malaria. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN, Lancet Infect Dis 2010 10 405 416
6. Plasmodium vivax in Africa: hidden in plain sight? [erratum appears in Trends Parasitol 2007; 23:304]. Rosenberg R, Trends Parasitol 2007 23 193 196
7. The neglected burden of Plasmodium vivax malaria. Mendis K, Sina BJ, Marchesini P, Carter R, Am J Trop Med Hyg 2001 64 97 106
8. Mapping the global extent of malaria in 2005. Guerra CA, Snow RW, Hay SI, Trends Parasitol 2006 22 353 358
9. Plasmodium vivax blood-stage dynamics. McKenzie FE, Jeffery GM, Collins WE, J Parasitol 2002 88 521 535
10. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in Northwestern India. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V, Am J Trop Med Hyg 2009 80 194 198
11. Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan. Beg MA, Sani N, Mehraj V, Jafri W, Khan MA, Malik A, Menezes E, Hussain R, Smego R, Int J Infect Dis 2008 12 37 42
12. Plasmodium vivax malaria. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A, Emerg Infect Dis 2005 11 132 134
13. Case reports: pernicious complications of benign tertian malaria. Lawn SD, Krishna S, Jarvis JN, Joet T, Macallan DC, Trans R Soc Trop Med Hyg 2003 97 551 553
14. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I, PLoS Med 2008 5 127
15. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in Northeastern Indonesian Papua. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, Elyazar I, Bangs MJ, Maguire JD, Baird JK, Am J Trop Med Hyg 2007 77 984 991
16. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN, PLoS Med 2008 5 128
17. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. Rodriguez-Morales AJ, Benitez JA, Arria M, J Trop Pediatr 2008 54 94 101
18. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Price RN, Douglas NM, Anstey NM, Curr Opin Infect Dis 2009 22 430 435
19. Neglect of Plasmodium vivax malaria. Baird JK, Trends Parasitol 2007 23 533 539
20. The 'non-falciparum' malarias: the roles of epidemiology, parasite biology, clinical syndromes, complications and diagnostic rigour in guiding therapeutic strategies. Maguire JD, Baird JK, Ann Trop Med Parasitol 2010 104 283 301
21. Severe and fatal vivax malaria challenges 'benign tertian malaria' dogma. Baird JK, Ann Trop Paediatr 2009 29 251 252
22. The pathophysiology of vivax malaria. Anstey NM, Russell B, Yeo TW, Price RN, Trends Parasitol 2009 25 220 227
23. Acute lung injury and other serious complications of Plasmodium vivax malaria. Tan LKK, Yacoub S, Scott S, Bhagani S, Jacobs M, Lancet Infect Dis 2008 8 449 454
24. Defying malaria: fathoming severe Plasmodium vivax disease. Bassat Q, Alonso PL, Nat Med 2011 17 48 49
25. Anemia and thrombocytopenia in children with Plasmodium vivax malaria. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M, J Trop Pediatr 2006 52 49 51
26. Is anemia in Plasmodium vivax malaria more frequent and severe than in Plasmodium falciparum? Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M, Franco-Paredes C, Am J Med 2006 119 9 e10
27. Vivax malaria: a major cause of morbidity in early infancy. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, Warikar N, Sugiarto P, Tjitra E, Anstey NM, Price RN, Clin Infect Dis 2009 48 1704 1712
28. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. Miller LH, Mason SJ, Clyde DF, McGinniss MH, N Engl J Med 1976 295 302 304
29. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau-Puijalon O, Zimmerman PA, Proc Natl Acad Sci U S A 2010 107 5967 5971
30. The risk of malarial infections and disease in Papua New Guinean children. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, Susapu M, Tarongka N, Zimmerman PA, Reeder JC, Beeson JG, Schofield L, King CL, Mueller I, Am J Trop Med Hyg 2007 76 997 1008
31. Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, Laumaea A, Schopflin S, Stanisic D, Betuela I, Blood-Zikursh M, Siba P, Felger I, Schofield L, Zimmerman P, Mueller I, PLoS One 2010 5 9047
32. Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. Ladeia-Andrade S, Ferreira MU, de Carvalho ME, Curado I, Coura JR, Am J Trop Med Hyg 2009 80 452 459
33. Southwest Pacific vivax malaria: clinical features and observations concerning duration of clinical activity. Hill E, Amatuzio DS, Am J Trop Med 1949 s1-29 203 214
34. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. Coatney GR, Cooper WC, Young MD, J Natl Malaria Soc 1950 9 381
35. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN, Clin Infect Dis 2008 46 1374 1381
36. Effects of Plasmodium vivax malaria in pregnancy. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ, Lancet 1999 354 546 549
37. Pregnancy outcomes associated with Plasmodium vivax malaria in Northeastern Venezuela. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M, Franco-Paredes C, Am J Trop Med Hyg 2006 74 755 757
38. Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Luzzatto L, Nwachuku-Jarrett ES, Reddy S, Lancet 1970 1 319 321
39. Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria. Roth EF, Friedman M, Ueda Y, Tellez I, Trager W, Nagel RL, Science 1978 202 650 652
40. Malaria and the red cell. Weatherall DJ, Miller LH, Baruch DI, Marsh K, Doumbo OK, Casals-Pascual C, Roberts DJ, Hematology 2002 35 57
41. Increased microerythrocyte count in homozygous alpha+thalassaemia contributes to protection against severe malarial anaemia. Fowkes FJI, Allen S, Allen A, Alpers MP, Weatherall DJ, Day KP, PLoS Med 2008 5 56
42. High incidence of malaria in alpha-thalassaemic children. Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TE, Newbold CI, Bowden DK, Weatherall DJ, Clegg JB, Nature 1996 383 522 525
43. Interaction of malaria with a common form of severe thalassemia in an Asian population. O'Donnell A, Premawardhena A, Arambepola M, Samaranayake R, Allen SJ, Peto TE, Fisher CA, Cook J, Corran PH, Olivieri NF, Weatherall DJ, Proc Natl Acad Sci U S A 2009 106 18716 18721
44. Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Zimmerman PA, Woolley I, Masinde GL, Miller SM, McNamara DT, Hazlett F, Mgone CS, Alpers MP, Genton B, Boatin BA, Kazura JW, Proc Natl Acad Sci U S A 1999 96 13973 13977
45. Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. Cattani JA, Gibson FD, Alpers MP, Crane GG, Trans R Soc Trop Med Hyg 1987 81 705 709
46. Reduced risk ofPlasmodium vivaxmalaria in Papua New Guinean children with South East Asian ovalocytosis. Rosanas-Urgell A, Lin E, Manning L, Rarau P, Laman M, Senn N, Grimberg BT, Tavul L, Stanisic D, Aponte J, Daboud E, Reeder JC, Siba P, Zimmerman PA, Davis TME, King CL, Michon P, Mueller I, Molecular Approaches to Malaria; Lorne, Victoria Walter and Eliza Hall Institute, Melbourne 2012 107
47. Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea. Patel SS, King CL, Mgone CS, Kazura JW, Zimmerman PA, Am J Hematol 2004 75 1 5
48. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, Casademont I, Sura T, Laird NM, Singhasivanon P, Quintana-Murci L, Sakuntabhai A, Science 2009 326 1546 1549
49. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. Leslie T, Briceno M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, Whitty CJ, Rowland M, PLoS Med 2010 7 1000283
50. Epidemiology of Plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, Snow RW, Hotez PJ, Am J Trop Med Hyg 2007 77 88 98
51. Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. Nacher M, Singhasivanon P, Yimsamran S, Manibunyong W, Thanyavanich N, Wuthisen R, Looareesuwan S, J Parasitol 2002 88 55 58
52. Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Spiegel A, Tall A, Raphenon G, Trape JF, Druilhe P, Trans R Soc Trop Med Hyg 2003 97 198 199
53. Complex interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border. Boel M, Carrara VI, Rijken M, Proux S, Nacher M, Pimanpanarak M, Paw MK, Moo O, Gay H, Bailey W, Singhasivanon P, White NJ, Nosten F, McGready R, PLoS Negl Trop Dis 2010 4 887
54. Concurrent helminthic infection protects schoolchildren with Plasmodium vivax from anemia. Melo GC, Reyes-Lecca RC, Vitor-Silva S, Monteiro WM, Martins M, Benzecry SG, Alecrim MG, Lacerda MV, PLoS One 2010 5 11206
55. Iron deficiency and malaria among children living on the coast of Kenya. Nyakeriga AM, Troye-Blomberg M, Dorfman JR, Alexander ND, Back R, Kortok M, Chemtai AK, Marsh K, Williams TN, J Infect Dis 2004 190 439 447
56. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM, Lancet 2006 367 133 143
57. Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy. Nacher M, McGready R, Stepniewska K, Cho T, Looareesuwan S, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2003 97 273 276
58. Zinc and iron supplementation and malaria, diarrhea, and respiratory infections in children in the Peruvian Amazon. Richard SA, Zavaleta N, Caulfield LE, Black RE, Witzig RS, Shankar AH, Am J Trop Med Hyg 2006 75 126 132
59. The effect of iron therapy on malarial infection in Papua New Guinean schoolchildren. Harvey PW, Heywood PF, Nesheim MC, Galme K, Zegans M, Habicht JP, Stephenson LS, Radimer KL, Brabin B, Forsyth K, Alpers MP, Am J Trop Med Hyg 1989 40 12 18
60. The infection of reticulocytes by Plasmodium vivax. Kitchen SF, Am J Trop Med Hyg 1938 s1-18 347 359
61. Observations on the parasitization of erythrocytes by Plasmodium vivax, with special reference to reticulocytes. Vryonis G, Am J Hyg 1939 30 41 48
62. Red cell selectivity in malaria: a study of multiple-infected erythrocytes. Simpson JA, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ, Trans R Soc Trop Med Hyg 1999 93 165 168
63. Age-structured red blood cell susceptibility and the dynamics of malaria infections. McQueen PG, McKenzie FE, Proc Natl Acad Sci U S A 2004 101 9161 9166
64. Population dynamics of a pathogen: the conundrum of vivax malaria. McQueen PG, Biophys Rev 2010 2 111 120
65. The dynamics of acute malaria infections. I. Effect of the parasite's red blood cell preference. Antia R, Yates A, de Roode JC, Proc Biol Sci 2008 275 1449 1458
66. The anaemia of P. falciparum malaria. Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M, Br J Haematol 1980 46 171 183
67. Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Jakeman GN, Saul A, Hogarth WL, Collins WE, Parasitology 1999 119 127 133
68. The anaemia of Plasmodium falciparum malaria. Weatherall DJ, Abdalla S, Br Med Bull 1982 38 147 151
69. Blood and bone marrow changes in malaria. Wickramasinghe SN, Abdalla SH, Baillieres Best Pract Res Clin Haematol 2000 13 277 299
70. Factors contributing to anemia after uncomplicated falciparum malaria. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirijaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ, Am J Trop Med Hyg 2001 65 614 622
71. Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia. Fendel R, Brandts C, Rudat A, Kreidenweiss A, Steur C, Appelmann I, Ruehe B, Schroder P, Berdel WE, Kremsner PG, Mordmuller B, PLoS One 2010 5 10038
72. Hematological impairments in recurrent Plasmodium vivax infected patients. Selvam R, Baskaran G, Jpn J Med Sci Biol 1996 49 151 165
73. A retrospective examination of anemia during infection of humans with Plasmodium vivax. Collins WE, Jeffery GM, Roberts JM, Am J Trop Med Hyg 2003 68 410 412
74. A quantitative ultrastructural study of the liver and the spleen in fatal falciparum malaria. Prommano O, Chaisri U, Turner GD, Wilairatana P, Ferguson DJ, Viriyavejakul P, White NJ, Pongponratn E, Southeast Asian J Trop Med Public Health 2005 36 1359 1370
75. The histopathology of therapeutic (tertian) malaria. Bruetsch WL, Am J Psychiatry 1932 89 19 65
76. Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria. Wickramasinghe SN, Looareesuwan S, Nagachinta B, White NJ, Br J Haematol 1989 72 91 99
77. Ferrokinetic studies and erythropoiesis in malaria. Srichaikul T, Wasanasomsithi M, Poshyachinda V, Panikbutr N, Rabieb T, Arch Intern Med 1969 124 623 628
78. Invasion of erythroblasts by Pasmodium vivax: a new mechanism contributing to malarial anemia. Ru YX, Mao BY, Zhang FK, Pang TX, Zhao SX, Liu JH, Wickramasinghe SN, Ultrastruct Pathol 2009 33 236 242
79. Non-pigmented malaria parasites in the bone marrow from a mixed infection of Leishmania and Plasmodium vivax. Yoeli M, Trans R Soc Trop Med Hyg 1948 42 99 101
80. Marchiafava E, Bignami A, On summer-autumnal malaria fevers The New Sydenham Society, London 1894
81. High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. Handayani S, Chiu DT, Tjitra E, Kuo JS, Lampah D, Kenangalem E, Renia L, Snounou G, Price RN, Anstey NM, Russell B, J Infect Dis 2009 199 445 450
82. Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Dondorp AM, Angus BJ, Chotivanich K, Silamut K, Ruangveerayuth R, Hardeman MR, Kager PA, Vreeken J, White NJ, Am J Trop Med Hyg 1999 60 733 737
83. Non-invasive in situ simultaneous measurement of multi-parameter mechanical properties of red blood cell membrane. Li J, Huang YX, Ji T, Tu M, Mao X, Chen WX, Chen GW, Acta Biochim Biophys Sin (Shanghai) 2005 37 391 395
84. Ex vivo perfusion of human spleens maintains clearing and processing functions. Buffet PA, Milon G, Brousse V, Correas JM, Dousset B, Couvelard A, Kianmanesh R, Farges O, Sauvanet A, Paye F, Ungeheuer MN, Ottone C, Khun H, Fiette L, Guigon G, Huerre M, Mercereau-Puijalon O, David PH, Blood 2006 107 3745 3752
85. Plasmodium falciparum maturation abolishes physiologic red cell deformability. Cranston HA, Boylan CW, Carroll GL, Sutera SP, Williamson JR, Gluzman IY, Krogstad DJ, Science 1984 223 400 403
86. The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Deplaine G, Safeukui I, Jeddi F, Lacoste F, Brousse V, Perrot S, Biligui S, Guillotte M, Guitton C, Dokmak S, Aussilhou B, Sauvanet A, Cazals Hatem D, Paye F, Thellier M, Mazier D, Milon G, Mohandas N, Mercereau-Puijalon O, David PH, Buffet PA, Blood 2011 117 88 e95
87. Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Safeukui I, Correas JM, Brousse V, Hirt D, Deplaine G, Mule S, Lesurtel M, Goasguen N, Sauvanet A, Couvelard A, Kerneis S, Khun H, Vigan-Womas I, Ottone C, Molina TJ, Treluyer JM, Mercereau-Puijalon O, Milon G, David PH, Buffet PA, Blood 2008 112 2520 2528
88. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. Pouvelle B, Buffet PA, Lepolard C, Scherf A, Gysin J, Nat Med 2000 6 1264 1268
89. Complement binding to erythrocytes is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria. Goka BQ, Kwarko H, Kurtzhals JA, Gyan B, Ofori-Adjei E, Ohene SA, Hviid L, Akanmori BD, Neequaye J, Trans R Soc Trop Med Hyg 2001 95 545 549
90. Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria. Pawluczkowycz AW, Lindorfer MA, Waitumbi JN, Taylor RP, J Immunol 2007 179 5543 5552
91. Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA, Blood 2000 95 1481 1486
92. Antibodies to the Plasmodium falciparum rhoptry protein RAP-2/RSP-2 in relation to anaemia in Cameroonian children. Awah N, Balogun H, Achidi E, Mariuba LA, Nogueira PA, Orlandi P, Troye-Blomberg M, Gysin J, Berzins K, Parasite Immunol 2011 33 104 115
93. Reduction in erythrocytic GSH level and stability in Plasmodium vivax malaria. Bhattacharya J, Swarup-Mitra S, Trans R Soc Trop Med Hyg 1987 81 64 66
94. Effects of malaria heme products on red blood cell deformability. Nuchsongsin F, Chotivanich K, Charunwatthana P, Omodeo-Sale F, Taramelli D, Day NP, White NJ, Dondorp AM, Am J Trop Med Hyg 2007 77 617 622
95. Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Omodeo-Sale F, Motti A, Dondorp A, White NJ, Taramelli D, Eur J Haematol 2005 74 324 332
96. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L, Lancet 1998 351 1768 1772
97. Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia. Thuma PE, van Dijk J, Bucala R, Debebe Z, Nekhai S, Kuddo T, Nouraie M, Weiss G, Gordeuk VR, J Infect Dis 2011 203 211 219
98. Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage. Layez C, Nogueira P, Combes V, Costa FT, Juhan-Vague I, da Silva LH, Gysin J, Blood 2005 106 3632 3638
99. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. de Mast Q, Syafruddin D, Keijmel S, Riekerink TO, Deky O, Asih PB, Swinkels DW, van der Ven AJ, Haematologica 2010 95 1068 1074
100. Increased erythropoietin production in children with severe malarial anemia. Burchard GD, Radloff P, Philipps J, Nkeyi M, Knobloch J, Kremsner PG, Am J Trop Med Hyg 1995 53 547 551
101. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkrumah FK, Hviid L, Br J Haematol 1997 97 169 174
102. Serum levels of erythropoietin in acute Plasmodium falciparum malaria. Burgmann H, Looareesuwan S, Kapiotis S, Viravan C, Vanijanonta S, Hollenstein U, Wiesinger E, Presterl E, Winkler S, Graninger W, Am J Trop Med Hyg 1996 54 280 283
103. Decreased erythropoietin response in Plasmodium falciparum malaria-associated anaemia. el Hassan AM, Saeed AM, Fandrey J, Jelkmann W, Eur J Haematol 1997 59 299 304
104. Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia. Gwamaka M, Fried M, Domingo G, Duffy PE, Malar J 2011 10 386
105. Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Fernandes AA, Carvalho LJ, Zanini GM, Ventura AM, Souza JM, Cotias PM, Silva-Filho IL, Daniel-Ribeiro CT, Clin Vaccine Immunol 2008 15 650 658
106. Characteristics of Plasmodium vivax-infected erythrocyte rosettes. Chotivanich KT, Pukrittayakamee S, Simpson JA, White NJ, Udomsangpetch R, Am J Trop Med Hyg 1998 59 73 76
107. Rosette formation by Plasmodium vivax. Udomsanpetch R, Thanikkul K, Pukrittayakamee S, White NJ, Trans R Soc Trop Med Hyg 1995 89 635 637
108. Variant genes and the spleen in Plasmodium vivax malaria. del Portillo HA, Lanzer M, Rodriguez-Malaga S, Zavala F, Fernandez-Becerra C, Int J Parasitol 2004 34 1547 1554
109. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. Anstey NM, Handojo T, Pain MCF, Kenangalem E, Tjitra E, Price RN, Maguire GP, J Infect Dis 2007 195 589 596
110. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. Suwanarusk R, Cooke BM, Dondorp AM, Silamut K, Sattabongkot J, White NJ, Udomsangpetch R, J Infect Dis 2004 189 190 194
111. An attempt to explain the greater pathogenicity of Plasmodium falciparum as compared with other species. Bass CC, Am J Trop Med 1921 s1-1 29 33
112. The haematology of Plasmodium vivax before and after chloroquine and primaquine treatment in North Madras area. Kumaresan PR, Selvam R, Indian J Malariol 1991 28 115 120
113. The paroxysm of Plasmodium vivax malaria. Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R, Trends Parasitol 2003 19 188 193
114. The role of cytokines in Plasmodium vivax malaria. Mendis KN, Carter R, Mem Inst Oswaldo Cruz 1992 87 Suppl 3 51 55
115. Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia. Yeo TW, Lampah DA, Tjitra E, Piera K, Gitawati R, Kenangalem E, Price RN, Anstey NM, J Infect Dis 2010 202 109 112
116. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale then in Plasmodium falciparum malaria. Hemmer CJ, Holst FGE, Kern P, Chiwakata CB, Dietrich M, Reisinger EC, Trop Med Int Health 2006 11 817 823
117. In vitro studies on peroxidative changes leading to hemolysis of erythrocytes infested with malarial parasite Plasmodium vivax. Meera S, Rao AV, D'Souza V, Rao SB, Indian J Exp Biol 1999 37 729 730
118. Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria. Erel O, Kocyigit A, Avci S, Aktepe N, Bulut V, Clin Biochem 1997 30 631 639
119. Malaria and anemia. Ekvall H, Curr Opin Hematol 2003 10 108 114
120. Malarial anaemia in African children associated with high oxygen-radical production. Greve B, Kremsner PG, Lell B, Luckner D, Schmid D, Lancet 2000 355 40 41
121. Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. Griffiths MJ, Ndungu F, Baird KL, Muller DP, Marsh K, Newton CR, Br J Haematol 2001 113 486 491
122. The sulphur requirements of the erythrocytic form of Plasmodium knowlesi. Fulton JD, Grant PT, Biochem J 1956 63 274 282
123. Malarial anemia: of mice and men. Lamikanra AA, Brown D, Potocnik A, Casals-Pascual C, Langhorne J, Roberts DJ, Blood 2007 110 18 28
124. Retention of erythrocytes in the spleen: a double-edged process in human malaria. Buffet PA, Safeukui I, Milon G, Mercereau-Puijalon O, David PH, Curr Opin Hematol 2009 16 157 164
125. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, Turner GD, Mercereau-Puijalon O, Blood 2011 117 381 392
126. Dynamic alteration in splenic function during acute falciparum malaria. Looareesuwan S, Ho M, Wattanagoon Y, White NJ, Warrell DA, Bunnag D, Harinasuta T, Wyler DJ, N Engl J Med 1987 317 675 679
127. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000 94 1 S90
128. Severe malaria in an unstable setting: clinical and laboratory correlates of cerebral malaria and severe malarial anemia and a paradigm for a simplified severity scoring. Giha HA, Elghazali G, Elgadir TM, Elbasit IE, Elbashir MI, Eur J Clin Microbiol Infect Dis 2009 28 661 665
129. Indicators of life-threatening malaria in African children. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley P, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R, N Engl J Med 1995 332 1399 1404
130. Malaria and the tropical splenomegaly syndrome in New Guinea. Crane GG, Pryor DS, Trans R Soc Trop Med Hyg 1971 65 315 324
131. Malarial antibodies in tropical splenomegaly syndrome in Papua New Guinea. Crane GG, Gardner A, Hudson P, Hudson B, Voller A, Trans R Soc Trop Med Hyg 1977 71 308 314
132. Pathological rupture of the spleen in malaria: analysis of 55 cases (1958-2008). Imbert P, Rapp C, Buffet PA, Travel Med Infect Dis 2009 7 147 159
133. Splenic complications in malaria: report of two cases from Turkey. Ozsoy MF, Oncul O, Pekkafali Z, Pahsa A, Yenen OS, J Med Microbiol 2004 53 1255 1258
134. Splenectomy in hereditary spherocytosis: effect on course of relapsing vivax malaria. Littman E, Am J Med Sci 1974 267 53 56
135. Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Looareesuwan S, Merry AH, Phillips RE, Pleehachinda R, Wattanagoon Y, Ho M, Charoenlarp P, Warrell DA, Weatherall DJ, Br J Haematol 1987 67 473 478
136. Cause of anaemia in malaria. Woodruff AW, Ansdell VE, Pettitt LE, Lancet 1979 1 1055 1057
137. Bone marrow changes in human malaria: a retrospective study. Gandapur AS, Malik SA, Raziq F, J Pak Med Assoc 1997 47 137 139
138. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Chang K-H, Stevenson MM, Int J Parasitol 2004 34 1501 1516
139. Defective erythropoietin production in the anaemia of malaria. Vedovato M, De Paoli Vitali E, Dapporto M, Salvatorelli G, Nephrol Dial Transplant 1999 14 1043 1044
140. The threshold of parasite density in relation to clinical activity in primary infections with Plasmodium vivax. Boyd MF, Am J Trop Med 1938 s1-18 497 503
141. Studies in human malaria: XVIII. The life pattern of sporozoite-induced St. Elizabeth strain vivax malaria. Coatney GR, Cooper WC, Ruhe DS, Young MD, Burgess RW, Am J Epid 1950 51 200
142. On the efficiency of the homologous properties of acquired immunity to Plasmodium vivax. Boyd MF, Kitchen SF, Am J Trop Med 1936 s1-16 447 457
143. Criteria of immunity and susceptibility in naturally induced vivax malaria infections. Boyd MF, Am J Trop Med 1942 s1-22 217 226
144. A retrospective examination of reinfection of humans with Plasmodium vivax. Collins WE, Jeffery GM, Roberts JM, Am J Trop Med Hyg 2004 70 642 644
145. On the duration of acquired homologous immunity to Plasmodium vivax. Boyd MF, Stratman-Thomas WK, Kitchen SF, Am J Trop Med 1936 s1-16 311 315
146. Recurring clinical activity in infections with the McCoy strain of Plasmodium vivax. Boyd MF, Kitchen SF, Am J Trop Med 1937 s1-17 833 843
147. Further observations on the duration of immunity to the homologous strain of Plasmodium vivax. Boyd MF, Matthews CB, Am J Trop Med 1939 s1-19 63 67
148. Renewed clinical activity in naturally induced vivax malaria. Boyd MF, Kitchen SF, Am J Trop Med 1944 s1-24 221 234
149. Some characteristics of foreign vivax malaria induced in neurosyphilitic patients. Young MD, Ellis JM, Stubbs TH, Am J Trop Med 1947 s1-27 585 596
150. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Douglas NM, Nosten F, Ashley EA, Phaipun L, van Vugt M, Singhasivanon P, White NJ, Price RN, Clin Infect Dis 2011 52 612 620
151. The genetic diversity of Plasmodium vivax populations. Cui L, Escalante AA, Imwong M, Snounou G, Trends Parasitol 2003 19 220 226
152. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ, J Infect Dis 2007 195 927 933
153. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q, J Infect Dis 2007 195 934 941
154. A deficient homologous immunity following simultaneous inoculation with two strains of Plasmodium vivax. Boyd MF, Kupper WH, Matthews CB, Am J Trop Med 1938 s1-18 521 524
155. Korean vivax malaria. I. natural history and response to chloroquine. Hankey DD, Jones R, Coatney GR, Alving AS, Coker WG, Garrison PL, Donovan WN, Am J Trop Med Hyg 1953 2 958 969
156. The Chesson strain ofPlasmodium vivaxmalaria III: clinical aspects. Whorton CM, Yount E, Jones R, Alving AS, J Infect Dis 1947 80 237 249
157. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T, Lancet 1987 2 1052 1055
158. Cryptic Plasmodium falciparum parasites in clinical P. vivax blood samples from Thailand. Siripoon N, Snounou G, Yamogkul P, Na-Bangchang K, Thaithong S, Trans R Soc Trop Med Hyg 2002 96 70 71
159. Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy. Brown AE, Kain KC, Pipithkul J, Webster HK, Trans R Soc Trop Med Hyg 1992 86 609 612
160. Plasmodium vivax and P. falciparum: biological interactions and the possibility of cross-species immunity. Maitland K, Williams TN, Newbold CI, Parasitol Today 1997 13 227 231
161. The epidemiology of severe malaria in an area of low transmission in Thailand. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ, Trans R Soc Trop Med Hyg 1997 91 256 262
162. Mixed-species malaria infections in humans. Mayxay M, Pukrittayakamee S, Newton PN, White NJ, Trends Parasitol 2004 20 233 240
163. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung M, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN, Lancet 2007 369 757 765
164. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Price RN, Nosten F, Drug Resist Updat 2001 4 187 196
165. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkenberg E, Whitty CJ, Rowland M, JAMA 2007 297 2201 2209
166. Comparative study of dihydroartemisinin and artesunate safety in healthy Thai volunteers. Kongpatanakul S, Chatsiricharoenkul S, Khuhapinant A, Atipas S, Kaewkungwal J, Int J Clin Pharmacol Ther 2009 47 579 586
167. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Phyo AP, Valecha N, Rao BHK, Tjitra E, Purnama A, Borghini-Fuhrer I, Duparc S, Shin C, Fleckenstein L, PLoS One 2011 6 14501
168. Selective toxicity of dihydroartemisinin on human CD34+ erythroid cell differentiation. Finaurini S, Ronzoni L, Colancecco A, Cattaneo A, Cappellini MD, Ward SA, Taramelli D, Toxicology 2010 276 128 134
169. Effects of amodiaquine, artesunate, and artesunate-amodiaquine on Plasmodium falciparum malaria-associated anaemia in children. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT, Acta Trop 2009 109 55 60
170. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, PLoS Med 2005 2 190
171. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Pukrittayakamee S, Imwong M, Chotivanich K, Singhasivanon P, Day NP, White NJ, Am J Trop Med Hyg 2010 82 542 547
172. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in Western Cambodia. Anderson TJC, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, Socheat D, Das D, Chotivanich K, Day NPJ, White NJ, Dondorp AM, J Infect Dis 2010 201 1326 1330
173. Status of immunity following cure of recurrent vivax malaria. Yount EH, Coggeshall LT, Am J Trop Med 1949 s1-29 701 705
174. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Hasugian AR, Purba HLE, Kenangalem E, Wuwung RM, Ebsworth EP, Maristela R, Penttinen PMP, Laihad F, Anstey NM, Tjitra E, Price RN, Clin Infect Dis 2007 44 1067 1074
175. A trial of combination antimalarial therapies in children from Papua New Guinea. Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TME, N Engl J Med 2008 359 2545 2557
176. Association of genetic mutations in Plasmodium vivax dhfr with resistance in sulfadoxine-pyrimethamine: geographical and clinical correlates. Imwong M, Pukrittayakamee S, Looareesuwan S, Pasvol G, Poirriez J, White NJ, Snounou G, Antimicrob Agents Chemother 2001 45 3122 3127
177. Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anaemia. Ekvall H, Premji Z, Bjorkman A, Trans R Soc Trop Med Hyg 1998 92 556 560
178. Primaquine therapy for malaria. Baird JK, Hoffman SL, Clin Infect Dis 2004 39 1336 1345
179. The hemolytic effect of primaquine and related compounds: a review. Beutler E, Blood 1959 14 103 139
180. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E, Blood Cells Mol Dis 2009 42 267 278
181. Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro. Baird JK, McCormick GJ, Canfield CJ, Biochem Pharmacol 1986 35 1099 1106
182. G6PD: population genetics and clinical manifestations. Beutler E, Blood Rev 1996 10 45 52
183. Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. Reeve PA, Toaliu H, Kaneko A, Hall JJ, Ganczakowski M, J Trop Med Hyg 1992 95 349 351
184. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE, Bull World Health Organ 1960 22 621 631
185. A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan. Leslie T, Mayan I, Mohammed N, Erasmus P, Kolaczinski J, Whitty CJ, Rowland M, PLoS ONE 2008 3 2861
186. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Clyde DF, Bull World Health Organ 1981 59 391 395
187. Drug-associated hemolytic anemia. Zalusky R, Bull N Y Acad Med 1970 46 427 437
188. Severe Plasmodium vivax malaria, Brazilian Amazon. Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, Lacerda MV, Alecrim MG, Emerg Infect Dis 2010 16 1611 1614
189. The epidemiology of malaria in a Karen population on the western border of Thailand. Luxemburger C, Thwai KL, White NJ, Webster HK, Kyle DE, Maelankirri L, Chongsuphajaisiddhi T, Nosten F, Trans R Soc Trop Med Hyg 1996 90 105 111
190. Haemoglobin levels in the D'Entrecasteaux Islands in relation to malaria and nutrition. Spencer TE, Med J Aust 1966 2 1093 1097
191. An analysis of anemia and pregnancy-related maternal mortality. Brabin BJ, Hakimi M, Pelletier D, J Nutr 2001 131 604S 614S discussion 614S-615S
192. An analysis of anemia and child mortality. Brabin BJ, Premji Z, Verhoeff F, J Nutr 2001 131 636S 645S discussion 646S-648S
193. Global database on blood safety: report 2004-2005 World Health Organization, Geneva 2008
194. The risk of transfusion-transmitted infections in sub-Saharan Africa. Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I, Transfusion 2010 50 433 442
195. Consequences of maternal anaemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea. Brabin BJ, Ginny M, Sapau J, Galme K, Paino J, Ann Trop Med Parasitol 1990 84 11 24
196. Swellengrebel NH, de Buck A, Malaria in The Netherlands Scheltema & Holkema Ltd., Amsterdam 1938
197. Situation analysis of malaria in school-aged children in Kenya-what can be done? Brooker S, Guyatt H, Omumbo J, Shretta R, Drake L, Ouma J, Parasitol Today 2000 16 183 186
198. Cognitive performance at school entry of children living in malaria-endemic areas of Sri Lanka. Fernando D, Wickremasinghe R, Mendis KN, Wickremasinghe AR, Trans R Soc Trop Med Hyg 2003 97 161 165
199. The impact of repeated malaria attacks on the school performance of children. Fernando SD, Gunawardena DM, Bandara MR, De Silva D, Carter R, Mendis KN, Wickremasinghe AR, Am J Trop Med Hyg 2003 69 582 588
200. Short-term impact of an acute attack of malaria on the cognitive performance of schoolchildren living in a malaria-endemic area of Sri Lanka. Fernando D, de Silva D, Wickremasinghe R, Trans R Soc Trop Med Hyg 2003 97 633 639
201. Plasmodium vivax: a cause of malnutrition in young children. Williams TN, Maitland K, Phelps L, Bennett S, Peto TE, Viji J, Timothy R, Clegg JB, Weatherall DJ, Bowden DK, QJM 1997 90 751 757
202. The economic and social burden of malaria. Sachs J, Malaney P, Nature 2002 415 680 685
203. Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study. Van den Eede P, Soto-Calle VE, Delgado C, Gamboa D, Grande T, Rodriguez H, Llanos-Cuentas A, Anne J, D'Alessandro U, Erhart A, PLoS One 2011 6 16257